Search results for Genomics-Precision Medicine

Operationalizing Precision Medicine 2026: U.S. Health Systems Scale Genetic Testing and AI Integration 

What You Should Know Precision medicine has transitioned from “one-off” testing to organized institutional programs at more than three-quarters of surveyed U.S. health systems, acc...

Precision Medicine’s Next Hurdle Isn’t Science — It’s Execution

A new UPMC report found that while most health systems now offer precision medicine programs, many still face challenges scaling them due to reimbursement, data integration and pat...

Life Science Update | March 2026

Advances in AI and genomic analysis will allow medical providers to tailor treatment for individual patients at the genome level, but challenges exist for protecting AI-assisted in...

HITLAB Validates IndyGeneUS Bio as Category Leader in Representative Genomic Intelligence

Independent Evidence Report Confirms Critical Gap in Global Genomic Data--and Identifies Scalable, Market-Ready Solution The post HITLAB Validates IndyGeneUS Bio as Category Leader...

Medgenome unveils india’s first study demonstrating the clinical impact of RNA-based NGS in sarcoma diagnosis

RNA sequencing improves sarcoma diagnosis by detecting gene fusions and refining classifications, enabling more accurate treatment decisions and better patient...

<![CDATA[Bridging the Precision Gap: Accelerating Clinical Adoption of Companion Diagnostics in Oncology]]>

The Conversation: Tapping Your Genome With AI And Quantum Computing Could Deliver on The Promise of Personalized Medicin...

From The Conversation By Gary Skuse, Professor of Bioinformatics, Rochester Institute of Technology and Sherry Dadgar, Clinical Assistant Professor of Medicine, George Washington U...

Gene Editing at Scale, Clinic Seeks Generalizable Therapies

What’s most exciting about CRISPR is its potential to shift medicine from managing disease to directly correcting its root cause. End-to-end pipelines and regulatory advances aim t...

Bostongene RNA transcriptome profiling reveals new ADC targets in advanced solid tumor

RNA sequencing combined with multiomic analysis uncovers new therapeutic targets in advanced cancers, enabling identification of antibody drug conjugate options when DNA testing al...

TRACERx MRD Results Showcase ppmSeq’s Ultra-Sensitive ctDNA Detection at AACR

Ultima Genomics will present ppmSeq MRD data at the AACR Annual Meeting, including TRACERx study findings, demonstrating ultra-sensitive whole-genome ctDNA detection at parts-per-m...

Genomic testing for advanced cancer improving but still lags

Nearly half of people diagnosed with advanced cancer over a recent 5-year period did not undergo next-generation sequencing, according to results of a retrospective cohort study.Ra...

Who Is Missing Out on Next-Generation Sequencing in Cancer?

RNA sequencing and genomic profiling adoption is rising across cancers, yet disparities in access and delayed testing continue to limit timely precision oncology treatment decision...

Rapid genomic testing helps 1,100 families worldwide target treatment for rare childhood disease

An international partnership designed to improve equality in access to genomic medicine for a rare disease has now provided potentially life-saving genetic testing for over 1,100 f...

It’s time to take genetic testing off the pedestal 

For years, genetic testing has been treated as something rare and exceptional—a highly specialized tool ordered only by geneticists and often reserved for the end of a long diagnos...

HELIX AI Model Accurately Predicts RNA Splicing, Unlocks Precision Medicine

A new AI-driven framework enables highly accurate prediction of RNA splicing and isoform usage for applications across splicing pathogenic variant interpretation and precision medi...

Next-generation sequencing has had a huge impact on molecular pathology lab

RNA sequencing and next generation sequencing expand cancer diagnostics by enabling multi gene analysis, improving mutation detection, and supporting targeted therapy decisions in...

New FDA recommendations support next-generation sequencing-based safety evaluation of off-target editing for personalise...

FDA draft guidance highlights next-generation sequencing approaches for evaluating off-target effects and genomic integrity in genome editing therapies, supporting safer gene thera...

Precision xenogenomics: a major milestone in bridging the organ gap

Building the Genome Grid

MGI Tech’s decade-long push helped turn sequencing into scalable, affordable global infrastructure. The post Building the Genome Grid appeared first on GEN - Genetic Engineering an...

AACR 2026: Lung Cancer Immunotherapy Response Predicted by Pathomics AI Model

Path-IO accurately stratified immunotherapy outcomes for patients with metastatic non-small cell lung cancer (NSCLC). The model is validated across international real-world cohorts...

The State of Multiomics & NGS

In our April 29 virtual summit GEN invites you to watch a superb line-up of presenters covering key topics in the world of multiomics, spatial biology, and NGS. The post The State...

Targeted Precision, Complex Promise

Antibody-drug conjugates (ADCs) have evolved from an elegant scientific concept into one of oncology’s most dynamic therapeutic classes. By fusing the targeting specificity of mono...

Detecting Disease at Its Molecular Origin

New screening technologies from Garage Brain Science aim to identify abnormal protein signals years before clinical symptoms develop. The post Detecting Disease at Its Molecular Or...

The $80,000 clue hiding in plain sight in U.S. healthcare

American healthcare faces a persistent paradox: We have extraordinary medical technology, yet patients often spend years navigating a system that treats symptoms before identifying...